AEA 01/2014

DRUG TEST 01

INSTRUCTIONS
1. Read the questions thoroughly
2. Answer all the questions on the answer sheet provided
3. Write neatly and legibly ensuring that your answers are clearly numbered.
4. Any attempt at examination fraud will result in immediate disqualification from the
assessment process.
PAGES: 6 (Including cover)
MARKS 62 Marks
TIME: 62 Minutes

NUMBER OF PAGES: 13 including

1
 AEA 01/2014
DRUG TEST 01

NAME:__________________________________________________________

DATE: __________________________________________________________

ORAL GLUCOSE POWDER/ GEL

1. DESCRIPTION (2)

_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
__________________

PHARMACOLOGICAL ACTION (1)

_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
__________________

ADVERSE EFFECTS (1)

_____________________________________________________________________
_____________________________________________________________________
____________

INDICATIONS (2)

_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
__________________

CONTRA-INDICATIONS (2)

_____________________________________________________________________
_____________________________________________________________________
____________

PRECAUTIONS (2)

_____________________________________________________________________
_____________________________________________________________________

2
 AEA 01/2014
DRUG TEST 01
_____________________________________________________________________
__________________

DOSAGE AND ADMINISTRATION (3)

_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
________________________

2. NITROUS OXIDE and OXYGEN (ENTONOX®)

DESCRIPTION (2)

_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
__________________

PHARMACOLOGICAL ACTION (6)

_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
________________________________________________

PHARMACO-KINETICS (4)

_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
______________________________

ADVERSE EFFECTS (3)

_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________

3
 AEA 01/2014
DRUG TEST 01
_____________________________________________________________________
______________________

INDICATIONS (5)

_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
__________________________________________

CONTRA-INDICATIONS (8)

• _______________________________________

_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
__________________

• _________________________________________

_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
______________________________

• ___________________________________________

_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
__________________

PRECAUTIONS (5)

_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________

4
 AEA 01/2014
DRUG TEST 01
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
__________________________________________________________________

PACKAGING (1)

_____________________________________________________________________
_____________________________________________________________________
____________

DOSAGE AND ADMINISTRATION (5)

_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_______________
3. ACTIVATED CHARCOAL

DESCRIPTION (2)

• Classification: _______________________________________________________
• Schedule: ____________________________________________________________

PHARMACOLOGICAL ACTION (1)

_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________

5
 AEA 01/2014
DRUG TEST 01

4. OXYGEN

PRECAUTIONS (7)

___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
_______________________________________________________

6
 AEA 01/2014
DRUG TEST 01